Stegeman, H., Kaanders, J. H., Verheijen, M. M., Peeters, W. J., Wheeler, D. L., Iida, M., . . . Bussink, J. (2013). Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines. BioMed Central.
シカゴスタイル引用形Stegeman, Hanneke, et al. Combining Radiotherapy With MEK1/2, STAT5 or STAT6 Inhibition Reduces Survival of Head and Neck Cancer Lines. BioMed Central, 2013.
MLA引用形式Stegeman, Hanneke, et al. Combining Radiotherapy With MEK1/2, STAT5 or STAT6 Inhibition Reduces Survival of Head and Neck Cancer Lines. BioMed Central, 2013.
警告: この引用は必ずしも正確ではありません.